Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$81,838,564
-$30,124,388 QoQ
Shares Held
1,707,104
-44.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#38
of 1,348 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$8,972,600
PutShares
130,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $2,303,425,127 across 13 Drug Manufacturers - General names. NVO ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,989,537 | $759,252,709 | |
| 2 | ABBV |
AbbVie Inc.
|
2,990,512 | $752,532,439 | |
| 3 | LLY |
ELI LILLY & Co
|
334,637 | $401,373,688 | |
| 4 | AZN |
Astrazeneca PLC
|
841,164 | $159,501,517 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
1,707,104 | $81,838,564 | |
| 6 | NVS |
Novartis AG
|
330,061 | $51,727,159 | |
| 7 | AMGN |
Amgen Inc
|
99,402 | $35,995,452 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
204,677 | $25,858,892 |
All Filings in NVO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,838,564 | 1,707,104 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $111,962,952 | 3,046,611 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $27,706,551 | 544,547 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $8,972,600 | 130,000 | Put | Other | 2025-08-13 | |
| 2025-06-30 | $2,153,424 | 31,200 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,744,680 | 25,125 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $100,428,177 | 1,167,498 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $21,587,746 | 181,303 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $98,696,287 | 691,441 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $256,800 | 2,000 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $24,194,782 | 233,879 | Shares | Other | 2024-02-14 | |
| 2023-06-30 | $18,435,026 | 113,916 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $5,053,649 | 31,756 | Shares | Other | 2023-05-15 | |
| 2022-09-30 | $1,154,910 | 11,592 | Shares | Other | 2022-11-14 | |
| 2022-03-31 | $407,109 | 3,666 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $508,368 | 4,539 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $1,269,444 | 13,222 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $1,161,116 | 16,623 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,279,942 | 47,241 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $48,942 | 813 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||